Oxford Bioscience Partners logo

Oxford Bioscience Partners

North America, Massachusetts, United States, Boston

Description

Oxford Bioscience Partners (OBP), established in 1992, is a venture capital firm that provides equity financing and management assistance

Investor Profile

Oxford Bioscience Partners has made 112 investments, with 0 in the past 12 months and 15% as lead.

Stage Focus

  • Series B (31%)
  • Series C (18%)
  • Series A (15%)
  • Series Unknown (14%)
  • Series D (9%)
  • Debt Financing (3%)
  • Series E (3%)
  • Series F (2%)
  • Undisclosed (2%)
  • Post Ipo Equity (2%)

Country Focus

  • United States (96%)
  • Switzerland (1%)
  • Tunisia (1%)
  • Germany (1%)
  • United Kingdom (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical Device
  • Pharmaceutical
  • Medical
  • Health Diagnostics
  • Manufacturing
  • Therapeutics
  • Life Science
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Oxford Bioscience Partners frequently co-invest with?

ABN AMRO Fund
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 6
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 9
Medica Venture Partners
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 7
HealthCare Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 13
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 9
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 7
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 7
Giza Venture Capital
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 8
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 7
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 11

Which angels does Oxford Bioscience Partners often collaborate with?

CW
North America, California, United States, San Francisco
Shared Deals: 1
AO
North America, California, United States, San Diego
Shared Deals: 1

What are some of recent deals done by Oxford Bioscience Partners?

Paperspace

Brooklyn, New York, United States

Hello, we're Paperspace Paperspace is the cloud platform built for the future.

Artificial Intelligence (AI)Cloud ComputingSaaSSoftware
Series FSep 27, 2021
0
Yolia Health

San Diego, California, United States

Yolia Health is a bio-medical device company committed to help people restore and enhance vision through non-invasive forms of treatment.

EducationHealth Care
Series AJan 1, 2017
Amount Raised: $3,000,000
CardioFocus

Marlborough, Massachusetts, United States

CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.

BiotechnologyHealth CareMedical DevicePharmaceutical
Debt FinancingMay 9, 2014
Amount Raised: $2,378,923
Affinium Pharmaceuticals

Austin, Texas, United States

Affinium Pharmaceuticals is a specialty pharmaceutical company, focused on the development of novel anti-infective medicines.

BiotechnologyHealth CarePharmaceutical
Debt FinancingSep 11, 2013
Amount Raised: $11,900,000
Dicerna Pharmaceuticals

Lexington, Massachusetts, United States

Dicerna Pharmaceuticals is a biotechnology company with a focus on the development of innovative treatments for rare inherited diseases.

BiotechnologyGeneticsHealth CarePharmaceutical
Series CJul 31, 2013
Amount Raised: $60,000,000
Mitralign

Tewksbury, Massachusetts, United States

Mitralign is focused on developing a catheter-based technology for the percutaneous treatments of functional mitral regurgitation.

Health CareMedicalMedical Device
Series DMay 16, 2012
Amount Raised: $35,000,000
Glori Energy

Houston, Texas, United States

Glori Energy is a tech company that offers AERO System to recover barrels of oil trapped in reservoirs to increase oil production.

Clean EnergyEnergyOil and GasRenewable Energy
Series CJan 24, 2012
Amount Raised: $20,000,000
CardioFocus

Marlborough, Massachusetts, United States

CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.

BiotechnologyHealth CareMedical DevicePharmaceutical
Series CFeb 28, 2011
Amount Raised: $30,600,000
SuperDimension

Minneapolis, Minnesota, United States

SuperDimension is a medical device company developing minimally invasive pulmonology devices for the treatment of distal lung disease.

Health CareMedicalMedical Device
Series UnknownSep 7, 2010
Amount Raised: $9,800,000
SuperDimension

Minneapolis, Minnesota, United States

SuperDimension is a medical device company developing minimally invasive pulmonology devices for the treatment of distal lung disease.

Health CareMedicalMedical Device
Debt FinancingSep 7, 2010
Amount Raised: $15,000,000